KAMADA Email Format

Pharmaceutical ManufacturingCentral District, Israel201-500 Employees

Kamada is a growing commercial-stage global biopharmaceutical company focused on the development and commercialization of specialty plasma-derived therapies for rare and serious conditions. The company has six FDA-approved products marketed in more than 30 countries, indicating its established position in the specialty plasma-derived field. It is based in Rehovot, Israel, and employs 201-500 people. Kamada maintains an active development pipeline targeting areas of significant unmet medical need. In June 2026, the company announced FDA approval for its in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) laboratory, a facility for measuring rabies-neutralizing antibodies.

Sign up for free to view info

Company overview Employee directory